Cargando…
The Effect of Statin on Anemia in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis
Although erythropoietin-stimulating agents are effective in treating anemia in patients with end-stage kidney disease (ESKD) undergoing hemodialysis, some ESKD patients, especially those with inflammation, continue to suffer from anemia. Statin, an inhibitor of hydroxymethylglutaryl-CoA (HMG-CoA) re...
Autores principales: | Tsai, Meng-Hsu, Su, Fu-You, Chang, Hao-Yun, Su, Po-Cheng, Chiu, Li-Yun, Nowicki, Michal, Kao, Chih-Chin, Lin, Yen-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317421/ https://www.ncbi.nlm.nih.gov/pubmed/35887674 http://dx.doi.org/10.3390/jpm12071175 |
Ejemplares similares
-
Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005–2012 Study
por: Su, Po-Cheng, et al.
Publicado: (2022) -
Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
por: Sung, Fung-Chang, et al.
Publicado: (2022) -
Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study
por: Sung, Fung-Chang, et al.
Publicado: (2022) -
Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
por: Gutiérrez, Orlando M.
Publicado: (2021) -
Machine learning to predict end stage kidney disease in chronic kidney disease
por: Bai, Qiong, et al.
Publicado: (2022)